25 XP   0   0   10

Ocugen Inc
Buy, Hold or Sell?

Let's analyse Ocugen together

PenkeI guess you are interested in Ocugen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ocugen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ocugen Inc

I send you an email if I find something interesting about Ocugen Inc.

Quick analysis of Ocugen (30 sec.)










What can you expect buying and holding a share of Ocugen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$0.33
Expected worth in 1 year
$0.14
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-0.18
Return On Investment
-15.5%

For what price can you sell your share?

Current Price per Share
$1.18
Expected price per share
$0.778 - $2.105
How sure are you?
50%

1. Valuation of Ocugen (5 min.)




Live pricePrice per Share (EOD)

$1.18

Intrinsic Value Per Share

$-3.52 - $-1.85

Total Value Per Share

$-3.19 - $-1.52

2. Growth of Ocugen (5 min.)




Is Ocugen growing?

Current yearPrevious yearGrowGrow %
How rich?$84m$95.8m-$11.7m-14.0%

How much money is Ocugen making?

Current yearPrevious yearGrowGrow %
Making money-$77.8m-$58.3m-$19.4m-25.0%
Net Profit Margin0.0%-254,646.6%--

How much money comes from the company's main activities?

3. Financial Health of Ocugen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#404 / 1010

Most Revenue
#722 / 1010

Most Profit
#945 / 1010

Most Efficient
#164 / 1010

What can you expect buying and holding a share of Ocugen? (5 min.)

Welcome investor! Ocugen's management wants to use your money to grow the business. In return you get a share of Ocugen.

What can you expect buying and holding a share of Ocugen?

First you should know what it really means to hold a share of Ocugen. And how you can make/lose money.

Speculation

The Price per Share of Ocugen is $1.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ocugen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ocugen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.33. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ocugen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.32-26.9%-0.32-26.9%-0.23-19.3%-0.17-14.0%-0.13-10.9%
Usd Book Value Change Per Share-0.05-3.9%-0.05-3.9%0.2924.5%0.076.3%0.043.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.4%0.000.2%
Usd Total Gains Per Share-0.05-3.9%-0.05-3.9%0.2924.5%0.086.7%0.043.7%
Usd Price Per Share1.30-1.30-4.55-1.66-2.65-
Price to Earnings Ratio-4.10--4.10--20.00--9.12--25.17-
Price-to-Total Gains Ratio-28.34--28.34-15.71-8.27--2.43-
Price to Book Ratio3.97-3.97-12.18-0.15-6.95-
Price-to-Total Gains Ratio-28.34--28.34-15.71-8.27--2.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.18
Number of shares847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.050.07
Usd Total Gains Per Share-0.050.08
Gains per Quarter (847 shares)-38.8567.44
Gains per Year (847 shares)-155.41269.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-155-16518252260
20-311-32036504530
30-466-47554755800
40-622-6307210071070
50-777-7859012591340
60-932-94010815111610
70-1088-109512617631880
80-1243-125014420142150
90-1399-140516222662420
100-1554-156018025182690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%5.06.00.045.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%1.00.010.09.1%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%5.06.00.045.5%

Fundamentals of Ocugen

About Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-11 16:34:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ocugen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ocugen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ocugen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-254,646.6%+254,646.6%
TTM-5Y-71,506.1%+71,506.1%
5Y-71,506.1%10Y-67,893.0%-3,613.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY-254,646.6%-288.3%-254,358.3%
5Y-71,506.1%-449.1%-71,057.0%
10Y-67,893.0%-605.5%-67,287.5%
1.1.2. Return on Assets

Shows how efficient Ocugen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • -71.6% Return on Assets means that Ocugen generated $-0.72 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ocugen Inc:

  • The MRQ is -71.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -71.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-71.6%TTM-71.6%0.0%
TTM-71.6%YOY-55.2%-16.5%
TTM-71.6%5Y-77.1%+5.4%
5Y-77.1%10Y-96.5%+19.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-71.6%-13.3%-58.3%
TTM-71.6%-12.8%-58.8%
YOY-55.2%-11.7%-43.5%
5Y-77.1%-13.9%-63.2%
10Y-96.5%-15.7%-80.8%
1.1.3. Return on Equity

Shows how efficient Ocugen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • -92.6% Return on Equity means Ocugen generated $-0.93 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ocugen Inc:

  • The MRQ is -92.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -92.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.6%TTM-92.6%0.0%
TTM-92.6%YOY-60.9%-31.7%
TTM-92.6%5Y-90.2%-2.4%
5Y-90.2%10Y-72.6%-17.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.6%-16.9%-75.7%
TTM-92.6%-16.1%-76.5%
YOY-60.9%-15.1%-45.8%
5Y-90.2%-19.3%-70.9%
10Y-72.6%-20.2%-52.4%

1.2. Operating Efficiency of Ocugen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ocugen is operating .

  • Measures how much profit Ocugen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ocugen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-253,176.3%+253,176.3%
TTM-5Y-67,269.4%+67,269.4%
5Y-67,269.4%10Y-43,522.2%-23,747.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY-253,176.3%-298.2%-252,878.1%
5Y-67,269.4%-492.1%-66,777.3%
10Y-43,522.2%-632.4%-42,889.8%
1.2.2. Operating Ratio

Measures how efficient Ocugen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ocugen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2,557.461-2,557.461
TTM-5Y645.499-645.499
5Y645.49910Y532.662+112.837
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY2,557.4613.890+2,553.571
5Y645.4995.739+639.760
10Y532.6627.876+524.786

1.3. Liquidity of Ocugen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ocugen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.34 means the company has $5.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ocugen Inc:

  • The MRQ is 5.335. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.335. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.335TTM5.3350.000
TTM5.335YOY14.664-9.328
TTM5.3355Y7.268-1.932
5Y7.26810Y5.877+1.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3353.890+1.445
TTM5.3354.173+1.162
YOY14.6645.344+9.320
5Y7.2686.126+1.142
10Y5.8776.448-0.571
1.3.2. Quick Ratio

Measures if Ocugen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Quick Ratio of 5.65 means the company can pay off $5.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ocugen Inc:

  • The MRQ is 5.650. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.650. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.650TTM5.6500.000
TTM5.650YOY14.278-8.628
TTM5.6505Y6.726-1.075
5Y6.72610Y5.575+1.151
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6503.514+2.136
TTM5.6503.998+1.652
YOY14.2785.380+8.898
5Y6.7266.105+0.621
10Y5.5756.404-0.829

1.4. Solvency of Ocugen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ocugen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ocugen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Ocugen assets are financed with 22.6% credit (debt) and the remaining percentage (100% - 22.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ocugen Inc:

  • The MRQ is 0.226. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.226. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.226TTM0.2260.000
TTM0.226YOY0.094+0.132
TTM0.2265Y0.381-0.154
5Y0.38110Y1.106-0.725
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2260.339-0.113
TTM0.2260.336-0.110
YOY0.0940.271-0.177
5Y0.3810.366+0.015
10Y1.1060.389+0.717
1.4.2. Debt to Equity Ratio

Measures if Ocugen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 29.2% means that company has $0.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ocugen Inc:

  • The MRQ is 0.292. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.292. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.2920.000
TTM0.292YOY0.104+0.189
TTM0.2925Y0.238+0.054
5Y0.23810Y0.336-0.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2920.388-0.096
TTM0.2920.402-0.110
YOY0.1040.335-0.231
5Y0.2380.426-0.188
10Y0.3360.461-0.125

2. Market Valuation of Ocugen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ocugen generates.

  • Above 15 is considered overpriced but always compare Ocugen to the Biotechnology industry mean.
  • A PE ratio of -4.10 means the investor is paying $-4.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ocugen Inc:

  • The EOD is -3.721. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.099. Based on the earnings, the company is expensive. -2
  • The TTM is -4.099. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.721MRQ-4.099+0.378
MRQ-4.099TTM-4.0990.000
TTM-4.099YOY-19.996+15.897
TTM-4.0995Y-9.116+5.017
5Y-9.11610Y-25.167+16.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.721-2.264-1.457
MRQ-4.099-2.629-1.470
TTM-4.099-2.680-1.419
YOY-19.996-4.145-15.851
5Y-9.116-6.257-2.859
10Y-25.167-6.254-18.913
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ocugen Inc:

  • The EOD is -4.690. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.167. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.167. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.690MRQ-5.167+0.477
MRQ-5.167TTM-5.1670.000
TTM-5.167YOY-23.877+18.710
TTM-5.1675Y-13.891+8.724
5Y-13.89110Y-26.640+12.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.690-2.973-1.717
MRQ-5.167-3.333-1.834
TTM-5.167-3.553-1.614
YOY-23.877-5.605-18.272
5Y-13.891-8.376-5.515
10Y-26.640-8.865-17.775
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ocugen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.97 means the investor is paying $3.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ocugen Inc:

  • The EOD is 3.601. Based on the equity, the company is fair priced.
  • The MRQ is 3.967. Based on the equity, the company is fair priced.
  • The TTM is 3.967. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.601MRQ3.967-0.366
MRQ3.967TTM3.9670.000
TTM3.967YOY12.180-8.213
TTM3.9675Y0.150+3.817
5Y0.15010Y6.955-6.805
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.6011.896+1.705
MRQ3.9672.115+1.852
TTM3.9672.093+1.874
YOY12.1802.884+9.296
5Y0.1503.542-3.392
10Y6.9553.916+3.039
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ocugen Inc.

3.1. Institutions holding Ocugen Inc

Institutions are holding 10.342% of the shares of Ocugen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc4.69390.0002120399181143660.959
2023-12-31BlackRock Inc1.43990.0001369328100
2023-12-31Geode Capital Management, LLC1.14230.00022929948684852.3934
2023-12-31Luminus Management, LLC0.63410.25861626583-1096073-40.2575
2023-12-31State Street Corporation0.32590835826-45800-5.1949
2023-12-31Northern Trust Corp0.19870.00015097496479614.5624
2023-12-31Group One Trading, LP0.19570.0008502051336918204.0283
2023-12-31Millennium Management LLC0.16020.0001410963-1213366-74.6995
2023-12-31Verition Fund Managegment, LLC0.15590.001840000000
2023-12-31Susquehanna International Group, LLP0.13470345591-79210-18.6464
2023-12-31GMT Capital Corp0.120.0067307786-3614412-92.1527
2023-12-31Morgan Stanley - Brokerage Accounts0.11550296169153485.4654
2023-12-31Cubist Systematic Strategies, LLC0.10350.001265469-48008-15.3147
2023-12-31Renaissance Technologies Corp0.0960.0002246173-674978-73.2755
2023-12-31T. Rowe Price Associates, Inc.0.072901871009300098.831
2023-12-31JPMorgan Chase & Co0.071301828134833635.9437
2023-12-31Charles Schwab Investment Management Inc0.0664017025400
2023-12-31Two Sigma Investments LLC0.06130.00021573042272216.8834
2023-12-31Bank of America Corp0.06050155181-49204-24.0742
2023-09-30D. E. Shaw & Co LP0.05420.0001139025-953244-87.2719
Total 9.90290.270125401184-7010324-27.6%

3.2. Funds holding Ocugen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.96170.0005759677300
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.22370.0029313886900
2024-01-31Fidelity Extended Market Index0.55550.0021142494700
2024-02-29Vanguard Health Care ETF0.33280.0038853701-46045-5.1176
2023-09-30BlackRock Extended Mkt Composite0.2320.001759515300
2023-12-31BlackRock Extended Equity Market K0.20240.0022519221-1046-0.2011
2024-01-31Fidelity Nasdaq Composite Index0.1930.001849512200
2024-01-31Fidelity Total Market Index0.18050.000346286310106727.9348
2024-01-31Fidelity Series Total Market Index0.12950.00033321726035722.2052
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.09970.00232558227168538.9303
2023-12-31Northern Trust Extended Eq Market Idx0.09170.0023235169-6802-2.8111
2023-12-31NT Ext Equity Mkt Idx Fd - L0.09170.0023235169-6802-2.8111
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.08010.00242054615785139.1918
2023-12-31T. Rowe Price U.S. Equities Tr0.07290.00121871009300098.831
2024-01-31Spartan Total Market Index Pool E0.07010.00031798917269867.8197
2024-02-29Schwab Total Stock Market Index0.06640.000717025400
2024-02-29Vanguard Balanced Index Inv0.05850.000315010000
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.05280.000413544300
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.05280.0002135443-7421418-98.2077
2024-01-31Fidelity ZERO Total Market Index0.03920.000310059800
Total 6.7870.028317409271-7025455-40.4%

3.3. Insider Transactions

Insiders are holding 1.453% of the shares of Ocugen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-14Junge ZhangBUY2002780.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ocugen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.046-0.0460%0.290-116%0.074-162%0.040-213%
Book Value Per Share--0.3280.3280%0.374-12%0.165+98%0.086+280%
Current Ratio--5.3355.3350%14.664-64%7.268-27%5.877-9%
Debt To Asset Ratio--0.2260.2260%0.094+141%0.381-41%1.106-80%
Debt To Equity Ratio--0.2920.2920%0.104+182%0.238+23%0.336-13%
Dividend Per Share----0%-0%0.005-100%0.003-100%
Eps---0.317-0.3170%-0.228-28%-0.166-48%-0.128-60%
Free Cash Flow Per Share---0.252-0.2520%-0.191-24%-0.127-49%-0.110-56%
Free Cash Flow To Equity Per Share---0.020-0.0200%0.280-107%0.077-126%0.036-155%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.851--------
Intrinsic Value_10Y_min---3.515--------
Intrinsic Value_1Y_max---0.127--------
Intrinsic Value_1Y_min---0.216--------
Intrinsic Value_3Y_max---0.425--------
Intrinsic Value_3Y_min---0.770--------
Intrinsic Value_5Y_max---0.778--------
Intrinsic Value_5Y_min---1.455--------
Market Cap302672360.000-10%333452600.000333452600.0000%1167084100.000-71%425177715.200-22%679935501.600-51%
Net Profit Margin----0%-2546.4660%-715.0610%-678.9300%
Operating Margin----0%-2531.7630%-672.6940%-435.2220%
Operating Ratio----0%2557.461-100%645.499-100%532.662-100%
Pb Ratio3.601-10%3.9673.9670%12.180-67%0.150+2545%6.955-43%
Pe Ratio-3.721+9%-4.099-4.0990%-19.996+388%-9.116+122%-25.167+514%
Price Per Share1.180-10%1.3001.3000%4.550-71%1.658-22%2.651-51%
Price To Free Cash Flow Ratio-4.690+9%-5.167-5.1670%-23.877+362%-13.891+169%-26.640+416%
Price To Total Gains Ratio-25.724+9%-28.340-28.3400%15.715-280%8.266-443%-2.433-91%
Quick Ratio--5.6505.6500%14.278-60%6.726-16%5.575+1%
Return On Assets---0.716-0.7160%-0.552-23%-0.771+8%-0.965+35%
Return On Equity---0.926-0.9260%-0.609-34%-0.902-3%-0.726-22%
Total Gains Per Share---0.046-0.0460%0.290-116%0.080-158%0.043-206%
Usd Book Value--84052000.00084052000.0000%95818000.000-12%42396170.400+98%22112985.200+280%
Usd Book Value Change Per Share---0.046-0.0460%0.290-116%0.074-162%0.040-213%
Usd Book Value Per Share--0.3280.3280%0.374-12%0.165+98%0.086+280%
Usd Dividend Per Share----0%-0%0.005-100%0.003-100%
Usd Eps---0.317-0.3170%-0.228-28%-0.166-48%-0.128-60%
Usd Free Cash Flow---64536000.000-64536000.0000%-48880000.000-24%-32628856.400-49%-28209128.200-56%
Usd Free Cash Flow Per Share---0.252-0.2520%-0.191-24%-0.127-49%-0.110-56%
Usd Free Cash Flow To Equity Per Share---0.020-0.0200%0.280-107%0.077-126%0.036-155%
Usd Market Cap302672360.000-10%333452600.000333452600.0000%1167084100.000-71%425177715.200-22%679935501.600-51%
Usd Price Per Share1.180-10%1.3001.3000%4.550-71%1.658-22%2.651-51%
Usd Profit---77834000.000-77834000.0000%-58365000.000-25%-37738212.200-52%-31184206.100-60%
Usd Revenue----0%22920.000-100%21632.000-100%11616.000-100%
Usd Total Gains Per Share---0.046-0.0460%0.290-116%0.080-158%0.043-206%
 EOD+3 -5MRQTTM+0 -0YOY+3 -285Y+7 -2610Y+10 -23

4.2. Fundamental Score

Let's check the fundamental score of Ocugen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.721
Price to Book Ratio (EOD)Between0-13.601
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.650
Current Ratio (MRQ)Greater than15.335
Debt to Asset Ratio (MRQ)Less than10.226
Debt to Equity Ratio (MRQ)Less than10.292
Return on Equity (MRQ)Greater than0.15-0.926
Return on Assets (MRQ)Greater than0.05-0.716
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Ocugen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.021
Ma 20Greater thanMa 501.545
Ma 50Greater thanMa 1001.242
Ma 100Greater thanMa 2000.874
OpenGreater thanClose1.270
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets108,632
Total Liabilities24,580
Total Stockholder Equity84,052
 As reported
Total Liabilities 24,580
Total Stockholder Equity+ 84,052
Total Assets = 108,632

Assets

Total Assets108,632
Total Current Assets98,492
Long-term Assets10,140
Total Current Assets
Cash And Cash Equivalents 77,563
Short-term Investments 13,371
Other Current Assets 7,558
Total Current Assets  (as reported)98,492
Total Current Assets  (calculated)98,492
+/-0
Long-term Assets
Property Plant Equipment 6,053
Long-term Assets Other 4,087
Long-term Assets  (as reported)10,140
Long-term Assets  (calculated)10,140
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,460
Long-term Liabilities6,120
Total Stockholder Equity84,052
Total Current Liabilities
Short-term Debt 498
Accounts payable 8,062
Other Current Liabilities 9,900
Total Current Liabilities  (as reported)18,460
Total Current Liabilities  (calculated)18,460
+/-0
Long-term Liabilities
Long term Debt 2,289
Capital Lease Obligations Min Short Term Debt3,587
Other Liabilities 244
Long-term Liabilities Other 244
Long-term Liabilities  (as reported)6,120
Long-term Liabilities  (calculated)6,364
+/- 244
Total Stockholder Equity
Common Stock2,217
Retained Earnings -213,018
Accumulated Other Comprehensive Income 26
Other Stockholders Equity 294,826
Total Stockholder Equity (as reported)84,052
Total Stockholder Equity (calculated)84,051
+/- 1
Other
Capital Stock2,218
Cash and Short Term Investments 90,934
Common Stock Shares Outstanding 214,600
Liabilities and Stockholders Equity 108,632
Net Debt -71,189
Net Invested Capital 86,340
Net Tangible Assets 84,051
Net Working Capital 80,032
Property Plant and Equipment Gross 6,674
Short Long Term Debt Total 6,374



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
21,044
14,796
65,499
36,786
36,078
11,035
17,428
16,807
27,376
105,761
108,632
108,632105,76127,37616,80717,42811,03536,07836,78665,49914,79621,044
   > Total Current Assets 
15,079
10,346
58,856
31,236
32,081
8,175
16,400
15,766
25,878
102,646
98,492
98,492102,64625,87815,76616,4008,17532,08131,23658,85610,34615,079
       Cash And Cash Equivalents 
14,716
8,734
58,060
30,915
31,908
7,081
15,542
7,444
24,039
94,958
77,563
77,56394,95824,0397,44415,5427,08131,90830,91558,0608,73414,716
       Short-term Investments 
0
0
0
0
0
900
0
0
0
0
13,371
13,371000090000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
4,988
0
04,988000000000
       Other Current Assets 
330
33
146
195
68
112
172
8,322,167
1,838,357
7,688
7,558
7,5587,6881,838,3578,322,1671721126819514633330
   > Long-term Assets 
5,965
4,450
6,643
5,550
3,997
2,860
1,028
1,041
1,499
3,115
10,140
10,1403,1151,4991,0411,0282,8603,9975,5506,6434,4505,965
       Property Plant Equipment 
2,315
2,283
4,878
5,213
3,860
2,723
141
222
633
1,164
6,053
6,0531,1646332221412,7233,8605,2134,8782,2832,315
       Intangible Assets 
630
570
510
200
0
0
0
0
0
0
0
0000000200510570630
       Long-term Assets Other 
540
539
604
137
137
137
887
668
714
1,800
4,087
4,0871,800714668887137137137604539540
> Total Liabilities 
40,755
90,350
11,293
8,588
22,511
22,303
17,886
5,789
5,826
9,943
24,580
24,5809,9435,8265,78917,88622,30322,5118,58811,29390,35040,755
   > Total Current Liabilities 
4,404
5,087
8,251
6,359
5,171
3,805
2,873
4,544
3,614
7,000
18,460
18,4607,0003,6144,5442,8733,8055,1716,3598,2515,0874,404
       Short-term Debt 
0
0
405
583
583
178
-8,868
172
278
363
498
498363278172-8,86817858358340500
       Short Long Term Debt 
0
0
0
0
583
178
0
0
234
0
0
00234001785830000
       Accounts payable 
1,042
2,530
4,886
2,253
1,948
776
1,590
1,896
395
2,312
8,062
8,0622,3123951,8961,5907761,9482,2534,8862,5301,042
       Other Current Liabilities 
3,362
2,557
125
548
508
835
151
206
10
293
9,900
9,900293102061518355085481252,5573,362
   > Long-term Liabilities 
36,351
85,263
3,042
2,229
17,340
18,498
15,013
1,245
2,212
2,943
6,120
6,1202,9432,2121,24515,01318,49817,3402,2293,04285,26336,351
       Long term Debt Total 
0
0
1,345
761
178
0
0
1,072
1,823
1,712
0
01,7121,8231,072001787611,34500
       Other Liabilities 
0
0
0
0
0
2
37
2
0
0
244
24400237200000
       Deferred Long Term Liability 
0
0
0
1,468
925
779
0
0
0
0
0
000007799251,468000
> Total Stockholder Equity
-19,711
-75,554
54,206
28,198
13,567
-11,268
-458
11,018
21,550
95,818
84,052
84,05295,81821,55011,018-458-11,26813,56728,19854,206-75,554-19,711
   Common Stock
6
6
127
132
159
159
513
527
1,841
1,995
2,217
2,2171,9951,84152751315915913212766
   Retained Earnings -213,018-131,667-73,302-51,480-216,830-208,187-181,773-165,565-133,541-110,748-85,036
   Accumulated Other Comprehensive Income 
-5,147
-5,649
-6,375
-7,989
-9,387
-10,919
-10,286
0
0
0
26
26000-10,286-10,919-9,387-7,989-6,375-5,649-5,147
   Capital Surplus 
0
0
187,620
193,631
195,181
196,760
215,859
62,019
93,059
225,537
0
0225,53793,05962,019215,859196,760195,181193,631187,62000
   Treasury Stock0-48-48-480000000
   Other Stockholders Equity 
70,466
40,837
128,496
201,620
204,568
207,679
226,145
61,971
93,011
225,489
294,826
294,826225,48993,01161,971226,145207,679204,568201,620128,49640,83770,466



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-81,058
Operating Income-81,058-81,058
 
Operating Expense (+$)
Research Development47,282
Selling General Administrative33,776
Selling And Marketing Expenses-
Operating Expense81,05881,058
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-81,058
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-75,524-86,592
EBIT - interestExpense = 0
-75,524
-75,524
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--75,524
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-75,524
Tax Provision--
Net Income From Continuing Ops-75,524-75,524
Net Income-75,524
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net5,5340
 

Technical Analysis of Ocugen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ocugen. The general trend of Ocugen is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ocugen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ocugen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.34 < 2.08 < 2.105.

The bearish price targets are: 1.09 > 0.802 > 0.778.

Tweet this
Ocugen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ocugen Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ocugen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ocugen Inc. The current macd is -0.00226724.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ocugen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ocugen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ocugen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ocugen Inc Daily Moving Average Convergence/Divergence (MACD) ChartOcugen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ocugen Inc. The current adx is 27.61.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ocugen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Ocugen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ocugen Inc. The current sar is 1.89421855.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ocugen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ocugen Inc. The current rsi is 40.02. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Ocugen Inc Daily Relative Strength Index (RSI) ChartOcugen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ocugen Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ocugen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ocugen Inc Daily Stochastic Oscillator ChartOcugen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ocugen Inc. The current cci is -137.73666757.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ocugen Inc Daily Commodity Channel Index (CCI) ChartOcugen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ocugen Inc. The current cmo is -38.35051683.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ocugen Inc Daily Chande Momentum Oscillator (CMO) ChartOcugen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ocugen Inc. The current willr is -96.77419355.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ocugen Inc Daily Williams %R ChartOcugen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ocugen Inc.

Ocugen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ocugen Inc. The current atr is 0.18303994.

Ocugen Inc Daily Average True Range (ATR) ChartOcugen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ocugen Inc. The current obv is -27,514,332.

Ocugen Inc Daily On-Balance Volume (OBV) ChartOcugen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ocugen Inc. The current mfi is 42.03.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ocugen Inc Daily Money Flow Index (MFI) ChartOcugen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ocugen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Ocugen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ocugen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.021
Ma 20Greater thanMa 501.545
Ma 50Greater thanMa 1001.242
Ma 100Greater thanMa 2000.874
OpenGreater thanClose1.270
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ocugen with someone you think should read this too:
  • Are you bullish or bearish on Ocugen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ocugen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ocugen Inc

I send you an email if I find something interesting about Ocugen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ocugen Inc.

Receive notifications about Ocugen Inc in your mailbox!